Qube Research & Technologies LTD Kiniksa Pharmaceuticals, Ltd. Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.63 - $21.74 $605,096 - $746,160	34,322 Added 36.32%	128,821 $2.54 Million
Q4 2023 Feb 13, 2024	BUY	$14.37 - $19.07 $252,365 - $334,907	17,562 Added 22.83%	94,499 $1.66 Million
Q3 2023 Nov 13, 2023	SELL	$13.62 - $20.2 $584,992 - $867,610	-42,951 Reduced 35.83%	76,937 $1.34 Million
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $71,012 - $112,096	-6,802 Reduced 5.37%	119,888 $1.69 Million
Q1 2023 May 15, 2023	BUY	$10.7 - $15.79 $1.36 Million - $2 Million	126,690 New	126,690 $1.36 Million
Q4 2021 Feb 01, 2022	SELL	$10.39 - $15.15 $333,944 - $486,936	-32,141 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.39 - $16.23 $366,085 - $521,648	32,141 New	32,141 $366,000
Q3 2020 Nov 12, 2020	SELL	$15.21 - $25.53 $307,561 - $516,242	-20,221 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $304,932 - $525,746	20,221 New	20,221 $515,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $690M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.